LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

Search

Stevanato Group SpA

Fechado

SetorSaúde

23 -1.63

Visão Geral

Variação de preço das ações

24h

Atual

Mín

22.73

Máximo

23

Indicadores-chave

By Trading Economics

Rendimento

10M

49M

Vendas

23M

303M

P/E

Médio do Setor

39.712

79.874

EPS

0.162

Rendimento de Dividendos

0.24

Margem de lucro

16.205

Funcionários

5,521

EBITDA

10M

73M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+19.76% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.24%

2.31%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-341M

6.4B

Abertura anterior

24.63

Fecho anterior

23

Sentimento de Notícias

By Acuity

50%

50%

168 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Stevanato Group SpA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de nov. de 2025, 16:49 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse in Talks to Buy Fund-Tech Platform Allfunds in $6 Billion Deal

27 de nov. de 2025, 15:32 UTC

Aquisições, Fusões, Aquisições de Empresas

TotalEnergies, Repsol in Talks to Combine U.K. North Sea Assets, Cinco Dias Says, Citing Sources

27 de nov. de 2025, 23:50 UTC

Conversa de Mercado

Nikkei May Trade Rangebound Amid Caution Over Economic Outlook -- Market Talk

27 de nov. de 2025, 23:50 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 de nov. de 2025, 16:05 UTC

Conversa de Mercado

Canadian Job Vacancies Rise for Fist Time Since Start of 2024 -- Market Talk

27 de nov. de 2025, 16:04 UTC

Conversa de Mercado

Canadian Payroll Employment Pulls Back in September, Offsetting Recent Gains -- Market Talk

27 de nov. de 2025, 15:54 UTC

Aquisições, Fusões, Aquisições de Empresas

Allfunds Shares Rise 21% After Deutsche Boerse Says Started Acquisition Talks

27 de nov. de 2025, 15:44 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse: No Certainty Talks Will Result in Transaction

27 de nov. de 2025, 15:43 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse: Allfunds Board of Directors Has Agreed to Enter Exclusive Talks

27 de nov. de 2025, 15:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse: Nonbinding Proposal is To Acquire Allfunds at EUR8.80 a Share

27 de nov. de 2025, 15:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Deutsche Boerse in Talks With Allfunds on Possible Acquisition

27 de nov. de 2025, 15:11 UTC

Conversa de Mercado

Dollar Could Fall in 2026 as U.S. Rate Cuts Bite -- Market Talk

27 de nov. de 2025, 14:26 UTC

Conversa de Mercado

Hermes' Outperformance Gap Could Narrow -- Market Talk

27 de nov. de 2025, 14:11 UTC

Conversa de Mercado

Lack of Major Budget Surprises Don't Justify Continued Sterling Strength -- Market Talk

27 de nov. de 2025, 14:11 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

27 de nov. de 2025, 13:35 UTC

Conversa de Mercado

Richemont Looks Set to Continue Outgrowing Peers -- Market Talk

27 de nov. de 2025, 13:33 UTC

Conversa de Mercado

Sterling's Post-Budget Gains Are Probably Over -- Market Talk

27 de nov. de 2025, 13:22 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

27 de nov. de 2025, 13:22 UTC

Conversa de Mercado

Kering's Plan to Revive Gucci Needs More Clarity -- Market Talk

27 de nov. de 2025, 13:17 UTC

Conversa de Mercado

LVMH Should Be Able to Recover Next Year -- Market Talk

27 de nov. de 2025, 11:13 UTC

Conversa de Mercado

European Gas Prices Come Under Pressure -- Market Talk

27 de nov. de 2025, 11:07 UTC

Ganhos

Genting: Positive About Prospects Over Longer Term

27 de nov. de 2025, 11:06 UTC

Ganhos

Genting: Cautious on Near-Term Prospects of Leisure, Hospitality Industry

27 de nov. de 2025, 11:04 UTC

Ganhos

Genting: International Travel Demand Expected to Remain Resilient

27 de nov. de 2025, 11:04 UTC

Ganhos

Genting: Global Growth Expected to Remain Subdued

27 de nov. de 2025, 11:04 UTC

Ganhos

Genting: Ebitda Partly Weighed by Stronger Ringgit Vs. Singapore Dollar, British Pound, U.S. Dollar

27 de nov. de 2025, 10:59 UTC

Ganhos

Genting Bhd 3Q Net Profit Fell 86% on Year

27 de nov. de 2025, 10:58 UTC

Ganhos

Genting Bhd 3Q Rev Rose 14% on Year

27 de nov. de 2025, 10:56 UTC

Ganhos

Genting Bhd 3Q Net MYR30.3M

27 de nov. de 2025, 10:56 UTC

Ganhos

Genting Bhd 3Q EPS MYR0.0079

Comparação entre Pares

Variação de preço

Stevanato Group SpA Previsão

Preço-alvo

By TipRanks

19.76% parte superior

Previsão para 12 meses

Média 28 USD  19.76%

Máximo 30 USD

Mínimo 26 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Stevanato Group SpA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

2

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

21.56 / 22.61Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

168 / 374 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat